Table 1.
Conventional Methodology | Observed Interference | Proposed Solution | |
---|---|---|---|
Cause | Result/Interpretation | ||
MTT reduction LDH leakage WST reduction |
NM optical density; NM aggregation in cell medium | Falsely increased viability | Sample centrifugation after cell lysis |
NM redox activity | Falsely decreased viability | None | |
ELISA (cytokine release) | Protein adsorption to NMs | Falsely decreased cytokine production | Add serum proteins to NM suspension |
Comet assay | Interference enzyme activity | Falsely decreased genotoxicity | None |
ROS quantification (H2DCF-DA) | NM redox activity | Falsely increased ROS levels | None |
NMs quench fluorescence; NMs scatter emitted fluorescence | Falsely decreased ROS levels | Sample centrifugation after cell lysis |
NM: nanomaterial; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; LDH: lactate dehydrogenase; WST: water-soluble tetrazolium salts; ELISA: enzyme-linked immunosorbent assay; ROS: reactive oxygen species; H2DCF-DA: 2′,7′-dichlorodihydrofluorescein diacetate.